Coherus Biosciences reported $320.35M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Aerie Pharmaceuticals AERI:US $ 118.13M 10.04M
Akebia Therapeutics AKBA:US $ 189.2M 23.61M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
ALKERMES ALKS:US $ 452.98M 69.54M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amarin AMRN:US $ 364.74M 5.69M
Amgen AMGN:US $ 14842M 257M
Baxter International BAX:US $ 3441M 97M
Biogen BIIB:US $ 4211.6M 864.4M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Coherus Biosciences CHRS:US $ 320.35M 33.3M
Eli Lilly And LLY:US $ 13682M 1411.2M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
Fujifilm 4901:JP Y 785948M 69479M
Gilead Sciences GILD:US $ 10245M 31M
Horizon Pharma HZNP:US $ 854.04M 1.23M
Ironwood Pharmaceuticals IRWD:US $ 145.69M 11.32M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
LG Chem 051910:KS KW 14865444M 262782M
Myriad Genetics MYGN:US $ 203.2M 67.8M
Pacira Pharmaceuticals PCRX:US $ 225.79M 2.9M
Perrigo Ordinary Shares PRGO:US $ 2003.8M 19.3M
Ptc Therapeutics PTCT:US $ 465.26M 174.3M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Revance Therapeutics RVNC:US $ 65.87M 7.63M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Teva Pharmaceutical TEVA:IT 11.82B 866M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
Xencor XNCR:US $ 44.32M 1.64M
Zoetis ZTS:US $ 1471M 620M